SOURCE: METI

METI

September 30, 2009 09:37 ET

METI's New Nurse Residency Program Aims to Help Reduce Health Industry Costs

The New Training Curriculum Is Designed to Reduce the Costs and Length of Orientation of New Nurses for Hospitals

SARASOTA, FL--(Marketwire - September 30, 2009) - METI, the Sarasota-based manufacturer of medical simulation products and educational software, today announced that it has begun rolling out its groundbreaking, experiential-based Nurse Residency Program at the first of many health care organizations throughout North America. Initially developed in partnership with Dartmouth-Hitchcock Medical Center, the Nurse Residency Program offers health care organizations significant savings in on boarding costs of new nurses by helping reduce turnover and vacancy rates.

Plans to implement the METI Nurse Residency Program are currently underway at a number of leading hospitals including Providence Health Care System in Alaska, Dayton VA Medical Center in Ohio, Sarasota Memorial Hospital in Florida, the Health and Hospitals Corporation in New York and Ephrata Community Hospital in Pennsylvania.

"Nursing shortages and rapidly increasing costs are very apparent at every level of health care," said Lou Oberndorf, Chairman and CEO of METI. "The Nurse Residency Program is designed to provide the industry with highly effective, advanced educational tools to help address some of these challenges and realize some very real savings."

The program integrates human patient simulation and other innovative approaches into the traditional didactic nursing orientation. What Dartmouth-Hitchcock and METI were able to prove, in a three year study of the program, was that the approach not only successfully reduced time and costs of orientation, but increased the ability to recruit new nurses and increased retention rates, overall productivity and efficacy -- potentially enabling hospitals to save millions of dollars in training costs.

About METI

Based in Sarasota, Florida, Medical Education Technologies, Inc. (METI®) has been a leader in interactive human patient simulation since 1996. Each METI simulator is designed to simulate bleeding, breathing, talking, blinking and numerous other physiological characteristics and various medical emergency scenarios including heart attack, drug overdose, vehicular accidents, effects from weapons of mass destruction, bio-terrorism and other traumatic injuries. More than 5,000 METI simulators are in use at organizations around the world, including leading medical schools such as the Mayo Clinic, Harvard, Cornell, Stanford and others.

Contact Information

  • For additional information, contact:
    Tess Mitchell
    Director of Marketing
    METI
    941.504.3255